Home » Archive

Channels

Conferences, Featured, SDBN Blog »

Targeting Protein-Protein Interactions For Drug Discovery

Posted by Sandeep Pingle May 15th, 2014 .
No Comments

Cambridge Healthtech Institute (CHI) organizes the annual Drug Discovery Chemistry (DDC) conference that focuses on drug discovery of small molecule candidates and challenges involved in their optimization. True to its motto “Optimizing Small Molecules For Tomorrow’s Therapeutics”, the DDC meeting that was held in San Diego from April 23-25, 2014 focused on multiple drug discovery platforms.
Small molecule drug discovery aims to treat clinical diseases by targeting specific molecules involved in the disease pathway(s). One of the most important targets for drug discovery is protein-protein interaction (PPI). PPIs are associated with …

More...

Conferences, Events, News, Syndication, Xconomy »

Appearing Briefly at Your Next Conference: “Whac-A-Mole” Speakers

Posted by sandiegobiotech March 31st, 2014 .
No Comments

Whac-A-Mole, for those of you who are not familiar with it, is a fast-paced arcade game in which mechanical moles pop quickly in and out of holes on a large board. You earn points by whacking them…

[[Click headline to continue reading.]]

More...

Conferences, Featured, SDBN Blog »

Society For Lab Screening And Automation 2014 Conference Recap #SLAS2014

Posted by Greg Mrachko January 30th, 2014 .
No Comments

The 3rd Annual Society of Laboratory and Automation Screening Conference (SLAS2014) was held at the San Diego Convention Center on 1/18-22.  It was a reprieve for many as it was an escape from the polar vortex in their home town, whereas for others it was a short commute to the harbor for $15/day parking in the convention garage or using a $12 three-day Trolley boarding pass.  Numerous major companies were featured such as Pfizer, Merck, AstraZeneca, GlaxoSmithKline, GNF, and Bristol-Myers Squibb plus universities, research institutes and a fair share of …

More...

Biotechnology, Conferences, Events, Featured, SDBN Blog »

Microbiome: The Next Big Biotech Bubble?

Posted by Claire Weston December 16th, 2013 .
No Comments

The Microbiome/Microbiota R&D Business Collaboration Forum kicked off in San Diego in October bringing together over 100 scientists and business executives from all over the globe.  This was a first-in-class research-business hybrid conference, stimulated in part by the completion of the Human Microbiome Project in June 2012 that published a rich source of sequencing data in the public domain.
It is estimated that there are at least 10,000 microbial species including bacteria, fungi and viruses residing in and on the human body, encoding millions of genes.  We have a limited understanding …

More...

Drug Discovery, Events, Headline, SDBN Blog, SDBN Events »

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

Posted by Mary Canady August 3rd, 2012 .
No Comments

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and the University of California, San Diego, and the La Jolla Institute for Allergy and Immunology. This new “collaboratory” opened in November of 2011, ideally located between the institutions in La Jolla, and demonstrates the power and potential of working together to fight disease. At our SDBN event August 21st, Evan Snyder, M.D., Ph.D., director of …

More...

Biotechnology, Drug Development, Featured, Medical Device, SDBN Blog »

INNOVATION: Finding the way from ordinary to extraordinary

Posted by Jessica Yingling June 12th, 2012 .
No Comments

The biggest question in entrepreneurship is how does one take an idea and make it reality, make it something that’s tangible and positively affects an individual and society as a whole. This was the theme at March’s SDBN networking event with Organovo, sponsored by Invetech.
Invetech helps companies translate innovations into breakthrough products.  They work with diagnostics, life sciences, medical devices, industrial, consumer and clean-tech industries.  Based in Australia, Invetech opened an office in San Diego in 2008 and has worked with a number of local companies including Organovo.
From idea to …

More...

Drug Discovery, Headline »

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

Posted by Mary Canady June 4th, 2012 .
No Comments

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, beginning with their acquisition of SGX Pharmaceuticals and Applied Molecular Evolution, and they’ve continued to move forward and contribute to the region.

The SDBN is dedicated to helping the local life science community understand and leverage the fantastic opportunities available through networking and sharing resources. Lilly is a leader in this area and formed the Open …

More...

Diagnostics, Drug Development, Drug Discovery, Featured, SDBN Blog »

San Diego’s Biotechnology Companies: Who’s Taking Off?

Posted by Lara March 8th, 2012 .
No Comments

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  But we also found a net gain in companies, with 68 added. We’ve begun to add some of the ‘provenances’ of new companies, as well as what’s happened to those that are no longer listed, and welcome your comments and additions as well, please leave them as a comment below. Note that some companies …

More...

Drug Development, Drug Discovery, Headline, SDBN Blog, SDBN Events »

SDBN March 26th 2012 Event with Organovo

Posted by Mary Canady March 6th, 2012 .
No Comments

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been included in the MIT Technology Review’s 2012 TR50 list of the world’s most innovative companies. The excitement around Organovo has grown since they recently announced funding and their stock is now publicly traded. You’ll get the chance to hear from CEO Keith Murphy at our March 26th event, he’ll give a presentation titled ‘3D Bioprinting …

More...

Biotechnology, Featured, SDBN Blog »

Getting a Scientist’s Attention at #SLAS2012

Posted by Lara February 14th, 2012 .
No Comments

Now that SLAS 2012 has wrapped up, the question is, amid all of those robotic arms, who truly stood out? We saw some great examples of vendors who were able to draw the crowds, while showcasing some pretty cool technology.
Here’s a list of some great ways to get a scientist’s attention, wonderfully demonstrated by three life science vendors at SLAS 2012.

Creativity counts. Rather than a bunch of cylinders and valves scattered about with some brochures on a table, Clippard center-staged an Air Guitar, rigged to be played.  How does …

More...